These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 39231780)

  • 1. A 6-month, prospective, randomized controlled trial of customized adherence enhancement versus a bipolar-specific educational control in poorly adherent adolescents and young adults living with bipolar disorder.
    Levin JB; DelBello M; Modi AC; Briggs F; Forthun LF; McVoy M; Yala J; Cooley R; Black J; Conroy C; Sajatovic M
    Bipolar Disord; 2024 Nov; 26(7):696-707. PubMed ID: 39231780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Symptom Severity and Medication Adherence in Adolescents with Bipolar Disorder Demonstrating Suboptimal Adherence.
    Sajatovic M; Levin JB; Modi A; McVoy M; Forthun LF; Cooley R; Black J; Conroy C; Sarna K; Briggs FB; DelBello M
    Psychopharmacol Bull; 2023 Aug; 53(3):8-21. PubMed ID: 37601085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 6-Month, Prospective, Randomized Controlled Trial of Customized Adherence Enhancement Versus Bipolar-Specific Educational Control in Poorly Adherent Individuals With Bipolar Disorder.
    Sajatovic M; Tatsuoka C; Cassidy KA; Klein PJ; Fuentes-Casiano E; Cage J; Aebi ME; Ramirez LF; Blixen C; Perzynski AT; Bauer MS; Safren SA; Levin JB
    J Clin Psychiatry; 2018 Sep; 79(6):. PubMed ID: 30256551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder.
    Sajatovic M; Levin J; Tatsuoka C; Micula-Gondek W; Fuentes-Casiano E; Bialko CS; Cassidy KA
    Bipolar Disord; 2012 May; 14(3):291-300. PubMed ID: 22548902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Acting Injectable Antipsychotic Medication Plus Customized Adherence Enhancement in Poor Adherence Patients With Bipolar Disorder.
    Sajatovic M; Levin JB; Ramirez LF; Cassidy KA; McNamara N; Fuentes-Casiano E; Wilson B; Appling D; S FB
    Prim Care Companion CNS Disord; 2021 Sep; 23(5):. PubMed ID: 34534421
    [No Abstract]   [Full Text] [Related]  

  • 6. A customized adherence enhancement program for adolescents and young adults with suboptimal adherence and bipolar disorder: Trial design and methodological report.
    McVoy M; Delbello M; Levin J; Modi AC; Forthun LF; Briggs F; Appling D; Broadnax M; Conroy C; Cooley R; Eapen G; Sajatovic M
    Contemp Clin Trials; 2022 Apr; 115():106729. PubMed ID: 35278693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Symptom Severity and Medication Adherence in Adults with Bipolar Disorder Reporting Adherence Challenges.
    Sajatovic M; Briggs F; Adeniyi C; Koopman J; Black J; Weise C; Fiorelli N; Yala J; Lesanpezeshki M; Einstadter D; Levin JB
    Psychopharmacol Bull; 2024 Jul; 54(3):60-72. PubMed ID: 38993661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom severity, self-reported adherence, and electronic pill monitoring in poorly adherent patients with bipolar disorder.
    Sajatovic M; Levin JB; Sams J; Cassidy KA; Akagi K; Aebi ME; Ramirez LF; Safren SA; Tatsuoka C
    Bipolar Disord; 2015 Sep; 17(6):653-61. PubMed ID: 26529124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Customized adherence enhancement for individuals with bipolar disorder receiving antipsychotic therapy.
    Sajatovic M; Levin J; Tatsuoka C; Micula-Gondek W; Williams TD; Bialko CS; Cassidy KA
    Psychiatr Serv; 2012 Feb; 63(2):176-8. PubMed ID: 22302337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-Related Differences in Medication Adherence, Symptoms, and Stigma in Poorly Adherent Adults With Bipolar Disorder.
    Smilowitz S; Aftab A; Aebi M; Levin J; Tatsuoka C; Sajatovic M
    J Geriatr Psychiatry Neurol; 2020 Sep; 33(5):250-255. PubMed ID: 31542988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trajectories of medication attitudes and adherence behavior change in non-adherent bipolar patients.
    Levin JB; Tatsuoka C; Cassidy KA; Aebi ME; Sajatovic M
    Compr Psychiatry; 2015 Apr; 58():29-36. PubMed ID: 25617964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interventional pilot of customized adherence enhancement combined with long-acting injectable antipsychotic medication (CAE-L) for poorly adherent patients with chronic psychotic disorder in Tanzania.
    Mbwambo J; Kaaya S; Lema I; Burant CJ; Magwiza C; Madundo K; Njiro G; Blixen CE; Cassidy KA; Levin JB; Sajatovic M
    BMC Psychiatry; 2022 Jan; 22(1):62. PubMed ID: 35086504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychoeducation for psychiatric inpatients following remission of a manic episode in bipolar I disorder: A randomized controlled trial.
    Chen R; Zhu X; Capitão LP; Zhang H; Luo J; Wang X; Xi Y; Song X; Feng Y; Cao L; Malhi GS
    Bipolar Disord; 2019 Feb; 21(1):76-85. PubMed ID: 29578271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of customized adherence enhancement (CAE-E): study protocol for a hybrid effectiveness-implementation project.
    Levin JB; Briggs F; Blixen C; Bauer M; Einstadter D; Albert JM; Weise C; Woods N; Fuentes-Casiano E; Cassidy KA; Rentsch J; Sarna K; Sajatovic M
    Trials; 2022 Aug; 23(1):634. PubMed ID: 35927740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illness experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication.
    Sajatovic M; Levin J; Fuentes-Casiano E; Cassidy KA; Tatsuoka C; Jenkins JH
    Compr Psychiatry; 2011; 52(3):280-7. PubMed ID: 21497222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of gender and gender identity to treatment adherence among individuals with bipolar disorder.
    Sajatovic M; Micula-Gondek W; Tatsuoka C; Bialko C
    Gend Med; 2011 Aug; 8(4):261-8. PubMed ID: 21763217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder.
    Sajatovic M; Levin J; Ramirez LF; Hahn DY; Tatsuoka C; Bialko CS; Cassidy KA; Fuentes-Casiano E; Williams TD
    J Clin Psychiatry; 2013 Dec; 74(12):1249-55. PubMed ID: 24434094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.